載入...
Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study
BACKGROUND: Evidence for pharmacogenetic risk stratification of angiotensin-converting enzyme inhibitor (ACEI) treatment is limited. Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two pharmacogenetic scores that previously...
Na minha lista:
發表在: | PLoS One |
---|---|
Main Authors: | , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4669156/ https://ncbi.nlm.nih.gov/pubmed/26633885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144195 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|